NEW ORLEANS, June 13, 2011 (GLOBE NEWSWIRE) -- Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUS), announced today that its Chief Executive Officer, Marvin S. Hausman MD, introduced a revolutionary new food ingredient to the attendees of the Institute of Food Technologists (IFT) Annual Meeting. The presentation was entitled: "Ergo-D2™ - A Novel Health Food Ingredient with Potent Anti-oxidant/Anti-inflammatory Activity;" Authors: Marvin S. Hausman, MD, Robert B. Beelman, PhD, Department of Food Science, Pennsylvania State University, State College, PA, and Krishna M. Bhat, PhD, Department of Neuroscience, University of Texas, Galveston, TX.
Ergo-D2™ is a breakthrough mushroom-based whole food natural ingredient formulated using proprietary TNS food technology that naturally enhances powerful bionutrients and antioxidants, such as L-Ergothioneine and vitamin D2, deficiencies of which have been implicated in inflammatory diseases such as heart disease, arthritis, Alzheimer's disease, cancer, multiple sclerosis and even acute depression. The presentation described significant results within biologic clinical models used to confirm this important new food ingredient's bionutrient activity and efficacy.
The introduction of Ergo-D2™ is extremely timely in view of the fact that worldwide vitamin D deficiency has been found to be very common in all age groups and that few foods contain vitamin D. The importance of vitamin D to human health was underscored by a clinical practice guideline, prepared by a special task force of doctors and just released by The Endocrine Society, titled: "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline." (J Clin Endocrinol Metab 96: 2011). In a recent news release, on June 6, 2011, a group of "Canadian Medical Associations Announce Support of Vitamin D Scientists' Call to D Action for Testing and Higher Serum Levels." (http://www.prweb.com/releases/2011/6/prweb8532353.htm).
About the Institute of Food Technologists
The Institute of Food Technologists or IFT is an international, non-profit professional organization for the advancement of food science and technology. It is the largest of food science organizations in the world, encompassing 22,000 members worldwide as of 2006. It is referred to as "The Society of Food Science and Technology." This year's annual meeting will be held in New Orleans, LA, from June 11-June 14, 2011. Dr. Hausman's presentation was featured in the "New Products & Technologies Tabletop Showcase."
About Total Nutraceutical Solutions, Inc.
TNS, a global biotechnology leader in whole food research and development, focuses on the discovery, formulation and marketing of functional ingredients and products addressing the multi-billion dollar markets for organic health, beauty and agriculture. The company's growing portfolio of intellectual property and formulations include some of the world's most powerful anti-oxidants and bionutrients occurring in nature. Founded in 2007 with a focus on specialty mushroom-based nutraceuticals, TNS is now expanding into other whole foods and using its proprietary clinical models and analytical tools to validate the benefits of its ingredients and the products that contain them.
| The Total Nutraceutical Solutions, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8060 |
Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Total Nutraceutical Solutions (TNS), Inc., with the Securities and Exchange Commission. Further information on risks faced by TNS are detailed in the Form 10-K for the year ended December 31, 2010, and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. TNS does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.